皮肌炎/多肌炎表观遗传学标志物的研究进展

doi:10.19723/j.issn.1671-167X.2019.02.035

Abstract

Abstract:

Idiopathic inflammatory myopathy (IIM) is a rare group of autoimmune diseases, characte-rized by chronic muscle weakness, muscle fatigue and infiltration of single nuclear cells in skeletal muscle. Its subtypes include dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM) and immune-mediated necrotizing myositis (IMNM), and the most common subtypes are DM and PM. PM is an autoimmune disease mainly manifested by muscle damage. When the skin is involved, it is called DM. The incidence of IIM was relatively low, which was 1.16-19 per million people/year, but the mortality was high and the prognosis was poor. The pathogenesis of IIM is still unclear. Previous stu-dies suggest that both immune and non-immune mechanisms are involved in its pathogenesis, especially cellular and humoral immunity. In recent years, researchers have conducted a number of studies on the pathogenesis of IIM, especially in the study of DM/PM with the application of high-throughput biome-trics. Epigenetics is a discipline that refers to the genetic phenomena of DNA methylation spectrum, chromatin structure state and gene expression spectrum transferred between cells without any changes in DNA sequence, including DNA methylation, chromatin modification and non-coding RNA changes. A large number of studies have shown that epigenetic modification plays an important role in many diseases, especially in cancer. Recent studies have also found a series of epigenetic markers related to the occurrence and development of DM/PM, mainly in the aspect of non-coding RNA changes, such as miR-10a, miR-206, etc.. And there has also been some research on DNA methylation. However, no studies have been reported on whether chromatin modification is involved in the pathogenesis of DM/PM. The pathogenesis of DM/PM is complex and diverse. With the development of research, certain microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) may become biological markers for the early diagnosis of DM/PM. Therefore, this paper mainly expounds the research progress of the biomarkers of DM/PM from the aspect of epigenetics.

Key words: Dermatomyositis, Polymyositis, Epigenomics, Biological markers

CLC Number:

R593.26

Yi-ying YANG,Xiao-xia ZUO,Hong-lin ZHU,Si-jia LIU. Advances in epigenetic markers of dermatomyositis/polymyositis[J].Journal of Peking University(Health Sciences), 2019, 51(2): 374-377.

References 38

[1]	Firestein GS, Budd RC, Gabriel SE, 等. 凯利风湿病学[M]. 8版. 栗占国, 唐福林, 左晓霞, 等译. 北京: 北京大学医学出版社, 2011.
[2]	Dimachkie MM, Barohn RJ, Amato A . Idiopathic inflammatory myopathies[J]. Neurol Clin, 2014,32(3):595-628. doi: 10.1016/j.ncl.2014.04.007
[3]	Meyer A, Meyer N, Schaeffer M , et al. Incidence and prevalence of inflammatory myopathies: a systematic review[J]. Rheumato-logy (Oxford), 2015,54(1):50-63. doi: 10.1093/rheumatology/keu289
[4]	Ernste FC, Reed AM . Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations[J]. Mayo Clin Proc, 2013,88(1):83-105. doi: 10.1016/j.mayocp.2012.10.017
[5]	Venalis P, Lundberg IE . Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy[J]. Rheumatology (Oxford), 2014,53(3):397-405. doi: 10.1093/rheumatology/ket279
[6]	Lu Gan, O’Hanlon TP, Gordon AS , et al. Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental in-fluences in pathogenesis[J]. BMC Musculoskelet Disord, 2014,15(1):1-11. doi: 10.1186/1471-2474-15-1
[7]	崔宏伟, 苏秀兰 . 表观遗传学研究进展[J]. 中国医药导报, 2014(19):152-155.
[8]	Boissonnas CC, Jouannet P, Jammes H . Epigenetic disorders and male subfertility[J]. Fertil Steril, 2013,99(3):624-631. doi: 10.1016/j.fertnstert.2013.01.124
[9]	Castelo-Branco G, Bannister AJ . The epigenetics of cancer from noncoding RNAs to chromatin and beyond[J]. Brief Funct Genomics, 2013,12(3):161-163. doi: 10.1093/bfgp/elt020
[10]	Toriello HV . What is new in the field of genetics[J]. Adolesc Med State Art Rev, 2013,24(1):43-56.
[11]	Carrió E, Suelves M . DNA methylation dynamics in muscle deve-lopment and disease[J]. Frontiers in Aging Neuroscience, 2015(7):19.
[12]	Wang M, Xie HH, Shrestha S , et al. Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity[J]. Arthritis Rheum, 2012,64(10):3478-3485. doi: 10.1002/art.34573
[13]	Gao SM, Zuo XX, Liu D , et al. The roles of neutrophil serine proteinases in idiopathic inflammatory myopathies[J]. Arthritis Res Ther, 2018,20(1):134. doi: 10.1186/s13075-018-1632-x
[14]	夏天, 肖丙秀, 郭俊明 . 长链非编码RNA的作用机制及其研究方法[J]. 遗传, 2013,35(3):269-280. doi: 10.3724/SP.J.1005.2013.00269
[15]	陈学斌, 王国春 . miRNA在特发性炎性肌病中的作用[J]. 实用医院临床杂志, 2015(5):17-22.
[16]	Xu D, Huang CC, Kachaochana A , et al. MicroRNA-10a regulation of proinflammatory mediators: an important component of untreated juvenile dermatomyositis[J]. J Rheumatol, 2016,43(1):161-168. doi: 10.3899/jrheum.141474
[17]	Chevrel G, Page G, Granet C , et al. Interleukin-17 increases the effects of IL-1β on muscle cells: arguments for the role of T cells in the pathogenesis of myositis[J]. J Neuroimmunol, 2003,137(1):125-133. doi: 10.1016/S0165-5728(03)00032-8
[18]	Lebson L, Gocke A, Rosenzweig J , et al. Cutting edge: the transcription factor Kruppel-like factor 4 regulates the differentiation of T17 cells independently of RORγt[J]. J Immunol, 2011,185(12):7161-7164.
[19]	An J, Golech S, Klaewsongkram J , et al. Kruppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during T17 differentiation[J]. FASEB J, 2011,25(10):3634-3645. doi: 10.1096/fj.11-186924
[20]	Parasramka MA, Dashwood WM, Wang R , et al. A role for low-abundance miRNAs in colon cancer: the miR-206/Kruppel-like factor 4 (KLF4) axis[J]. Clin Epigenetics, 2012,4(1):16-26. doi: 10.1186/1868-7083-4-16
[21]	Tang XY, Tian XY, Zhang Y , et al. Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis[J]. Clin Dev Immunol, 2013,2013:345347.
[22]	Misunova M, Salinas-Riester G, Luthin S , et al. Microarray ana-lysis of circulating micro RNAs in the serum of patients with polymyositis and dermatomyositis reveals a distinct disease expression profile and is associated with disease activity[J]. Clin Exp Rheumatol, 2016,34(1):17-24.
[23]	Georgantas RW, Streicher K, Greenberg SA , et al. Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies[J]. Arthritis Rheumatol, 2014,66(4):1022-1033. doi: 10.1002/art.38292
[24]	Arahata K, Engel AG . Monoclonal antibody analysis of mononuclear cells in myopathies I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells[J]. Ann Neurol, 1984,16(2):193-208. doi: 10.1002/(ISSN)1531-8249
[25]	Greenberg SA, Bradshaw EM, Pinkus JL , et al. Plasma cells in muscle in inclusion body myositis and polymyositis[J]. Neurology, 2005,65(11):1782-1787. doi: 10.1212/01.wnl.0000187124.92826.20
[26]	Greenberg SA, Pinkus GS, Amato AA , et al. Myeloid dendritic cells in inclusion-body myositis and polymyositis[J]. Muscle Nerve, 2007,35(1):17-23. doi: 10.1002/(ISSN)1097-4598
[27]	Zhu W, Streicher K, Shen N , et al. Genomic signatures characterize leukocyte infiltration in myositis muscles[J]. BMC Med Genomics, 2012,5(1):53-64. doi: 10.1186/1755-8794-5-53
[28]	Oshikawa Y, Jinnin M, Makino T , et al. Decreased miR-7 expression in the skin and sera of patients with dermatomyositis[J]. Acta Derm Venereol, 2013,93(3):273-276. doi: 10.2340/00015555-1459
[29]	Inoue K, Jinnin M, Yamane K , et al. Down-regulation of miR-223 contributes to the formation of Gottron’s papules in dermatomyositis via the induction of PKC varepsilon[J]. Eur J Dermatol, 2013,23(2):160-167.
[30]	Hirai T, Ikeda K, Tsushima H , et al. Circulating plasma micro-RNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis[J]. Inflamm Regen, 2018,38:1. doi: 10.1186/s41232-017-0058-1
[31]	Zhou B, Zuo XX, Li YS , et al. Integration of microRNA and mRNA expression profiles in the skin of systemic sclerosis patients[J]. Sci Rep, 2017,7:42899. doi: 10.1038/srep42899
[32]	Simionescu-Bankston A, Kumar A . Noncoding RNAs in the regulation of skeletal muscle biology in health and disease[J]. J Mol Med, 2016,94(8):853-866. doi: 10.1007/s00109-016-1443-y
[33]	Butchart LC, Fox A, Shavlakadze T , et al. The long and short of non-coding RNAs during post-natal growth and diferentiation of skeletal muscles: Focus on lncRNA and miRNAs[J]. Differentiation, 2016,92(5):237-248. doi: 10.1016/j.diff.2016.05.003
[34]	Rinn JL, Chang HY . Genome regulation by long noncoding RNAs[J]. Annu Rev Biochem, 2012,81(1):145-166. doi: 10.1146/annurev-biochem-051410-092902
[35]	Wapinski O, Chang HY . Long noncoding RNAs and human di-sease[J]. Trends Cell Biol, 2011,21(6):354-361. doi: 10.1016/j.tcb.2011.04.001
[36]	Peng QL, Zhang YM, Yang HB , et al. Transcriptomic profiling of long non-coding RNAs in dermatomyositis by microarray analysis[J]. Sci Rep, 2016,6:32818. doi: 10.1038/srep32818
[37]	Hamann PD, Roux BT, Heward JA , et al. Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis[J]. Sci Rep, 2017,7:8024. doi: 10.1038/s41598-017-08603-9
[38]	Gao SM, Luo H, Zhang HL , et al. Using multi-omics methods to understand dermatomyositis/polymyositis[J]. Autoimmun Rev, 2017,16(10):1044-1048. doi: 10.1016/j.autrev.2017.07.021

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2]	. [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3]	. [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4]	. [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5]	. [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6]	. [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7]	. [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8]	. [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9]	. [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10]	. [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .

Advances in epigenetic markers of dermatomyositis/polymyositis

RICH HTML

PDF (PC)

Abstract

Cite this article

share this article

References 38

Related Articles 9

Metrics

Comments

Recommended 10

[1]	Pu-li ZHANG,Hong-xia YANG,Li-ning ZHANG,Yong-peng GE,Qing-lin PENG,Guo-chun WANG,Xin LU. Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1055-1060.
[2]	Yu-zhou GAN,Yu-hui LI,Li-hua ZHANG,Lin MA,Wen-wen HE,Yue-bo JIN,Yuan AN,Zhan-guo LI,Hua YE. Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1001-1008.
[3]	Jing XU,Jing XU,He LI,Jie TANG,Jian-long SHU,Jing ZHANG,Lian-jie SHI,Sheng-guang LI. Dermatomyositis combined with IgA vasculitis: A case report [J]. Journal of Peking University(Health Sciences), 2019, 51(6): 1173-1177.
[4]	Jiao YANG,Hai-hong YAO,Xiao-dong MO,Zeng LUO,yang-jin Bai-ma. Clinical and immunological characteristics of patients with systemic lupus erythematosus in Tibet plateau, China [J]. Journal of Peking University(Health Sciences), 2018, 50(6): 1004-1008.
[5]	YU Jian-feng, JIN Yue-bo, HE Jing, AN Yuan, LI Zhan-guo. Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren’s syndrome: a case report [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 910-914.
[6]	GONG Bei, HU Hui-Hui, ZHANG Man. Expression of apolipoprotein A-Ⅰ in eight histological types of renal neoplasms [J]. Journal of Peking University(Health Sciences), 2015, 47(1): 155-159.
[7]	LIU Shuang, AN Yuan, JIA Yuan, LI Zhan-Guo. A case of clinical overlap syndrome of rheumatoid arthritis and amyopathic dermatomyositis with multiple pulmonary injuries [J]. Journal of Peking University(Health Sciences), 2014, 46(5): 805-808.
[8]	YAO Yi-Sang, GAO Ling, LI Yu-Ling, MA Shao-Li, WU Zi-Mei, TAN Ning-Zhi, WU Jian-Yong, NI Lu-Qun, ZHU Jia-Shi. Amplicon density-weighted algorithms for analyzing dissimilarity and dynamic alterations of RAPD polymorphisms of Cordyceps sinensis [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 618-628.
[9]	LIU Yuan, WANG Yong-Fu, WANG Kai-Li, 吕Feng-Feng . Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjögren’s syndrome patients [J]. Journal of Peking University(Health Sciences), 2014, 46(3): 478-482.